Drugs / Estradiol Tablets
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05663892 | Nov 2022 → Nov 2024 overdue | HIV infectious disease | Maple Leaf Research | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Estradiol Tablets | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05663892 ↗ |
| Route | Oral | “Oral 17(beta)-estradiol as the estrogen” NCT05663892 ↗ |